Literature DB >> 20562259

Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system.

Reza Khorooshi1, Trevor Owens.   

Abstract

Innate glial response is critical for the induction of inflammatory mediators and recruitment of leukocytes to sites of the injury in the CNS. We have examined the involvement of type I IFN signaling in the mouse hippocampus following sterile injury (transection of entorhinal afferents). Type I IFNs signal through a receptor (IFNAR), which involves activation of IFN regulatory factor (IRF)9, leading to the induction of IFN-stimulated genes including IRF7, that in turn enhances the induction of type I IFN. Axonal transection induced upregulation of IRF7 and IRF9 in hippocampus. Induction of IRF7 and IRF9 mRNAs was IFNAR dependent. Double-labeling immunofluorescence showed that IRF7 selectively was induced in Mac-1/CD11b(+) macrophages/microglia in hippocampus after axonal transection. IRF7 mRNA was also detected in microglia sorted by flow cytometry. Lack of type I IFN signaling resulted in increased leukocyte infiltration into the lesion-reactive hippocampus. Axonal lesion-induced CXCL10 gene expression was abrogated, whereas matrix metalloproteinase 9 mRNA was elevated in IFNAR-deficient mice. Our findings point to a role for type I IFN signaling in regulation of CNS response to sterile injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562259     DOI: 10.4049/jimmunol.0901753

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Astrogliosis involves activation of retinoic acid-inducible gene-like signaling in the innate immune response after spinal cord injury.

Authors:  Juan Pablo de Rivero Vaccari; Julia Minkiewicz; Xiaoliang Wang; Juan Carlos De Rivero Vaccari; Ramon German; Alex E Marcillo; W Dalton Dietrich; Robert W Keane
Journal:  Glia       Date:  2011-12-07       Impact factor: 7.452

2.  Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons.

Authors:  Suneil Hosmane; Million Adane Tegenge; Labchan Rajbhandari; Prech Uapinyoying; Nishant Ganesh Kumar; Nitish Thakor; Arun Venkatesan
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

3.  Reactive oxygen species and IRF1 stimulate IFNα production by proximal tubules during ischemic AKI.

Authors:  Pamela D Winterberg; Yanxia Wang; Keng-Mean Lin; John R Hartono; Glenn T Nagami; Xin J Zhou; John M Shelton; James A Richardson; Christopher Y Lu
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-08

4.  Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.

Authors:  Raffaella Gesuete; Amy E B Packard; Keri B Vartanian; Valerie K Conrad; Susan L Stevens; Frances R Bahjat; Tao Yang; Mary P Stenzel-Poore
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

5.  Sirtuin 1-Chromatin-Binding Dynamics Points to a Common Mechanism Regulating Inflammatory Targets in SIV Infection and in the Aging Brain.

Authors:  Nikki Bortell; Liana Basova; Julia A Najera; Brenda Morsey; Howard S Fox; Maria Cecilia Garibaldi Marcondes
Journal:  J Neuroimmune Pharmacol       Date:  2017-12-26       Impact factor: 4.147

6.  A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.

Authors:  Nicole A de Weerd; Antony Y Matthews; Phillip R Pattie; Nollaig M Bourke; San S Lim; Julian P Vivian; Jamie Rossjohn; Paul J Hertzog
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

Review 7.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 8.  Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity.

Authors:  Colm Cunningham; Aisling Dunne; Ana Belen Lopez-Rodriguez
Journal:  Neuroscientist       Date:  2018-11-17       Impact factor: 7.519

9.  Correction to: Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 10.  How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.

Authors:  Anthony T Reder; Xuan Feng
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.